Ansuman brings venture capital, board, and scientific advisory experience from roles at Wing, Chemify Limited, and Stanford University. He previously co-founded Arpelos Biosciences.
The oversubscribed round will scale automated laboratories and molecular design operations.
"Chemify aims to become the global digital backbone of chemistry, enabling fast design and discovery. Our vision is that Chemify will be able to design and make any molecule on demand for our customers across all of chemistry from drug discovery to new catalysts and electronic materials. The next step in our evolution is nothing short of a revolution in the digitization and automation of chemical discovery and manufacturing."
The round was led by Buckley Ventures and will fund manufacturing and distribution scale-up.
"The most tedious process in biotech is growing human cells by hand. Every scientist needs to spend hours a day growing cells and coming in on weekends to look after them,"
The seed round was led by Wing VC with participation from Notion Capital, Seedcamp, Connect Ventures, and Tiny VC.
"The companies that win big in the next decade will be those that proactively build closer, more authentic relationships with their user community. Outverse will offer companies a complete ecosystem for staying close to their customers, enabling a new generation of iconic products and businesses to emerge."
